These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1052 related items for PubMed ID: 7714076
61. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Baker MS, Bleakley P, Woodrow GC, Doe WF. Cancer Res; 1990 Aug 01; 50(15):4676-84. PubMed ID: 2114945 [Abstract] [Full Text] [Related]
62. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO. Invest Ophthalmol Vis Sci; 2002 Aug 01; 43(8):2799-805. PubMed ID: 12147618 [Abstract] [Full Text] [Related]
63. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis. Sandberg T, Casslén B, Gustavsson B, Benraad TJ. Biol Reprod; 1998 Oct 01; 59(4):759-67. PubMed ID: 9746723 [Abstract] [Full Text] [Related]
64. Inhibition of plasminogen activators attenuates the death of differentiated retinal ganglion cells and stabilizes their neurite network in vitro. Harvey R, Chintala SK. Invest Ophthalmol Vis Sci; 2007 Apr 01; 48(4):1884-91. PubMed ID: 17389524 [Abstract] [Full Text] [Related]
65. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Gross TJ, Simon RH, Kelly CJ, Sitrin RG. Am J Physiol; 1991 Apr 01; 260(4 Pt 1):L286-95. PubMed ID: 1902065 [Abstract] [Full Text] [Related]
66. Regulation of plasminogen activators in human thyroid follicular cells and their relationship to differentiated function. Susarla R, Watkinson JC, Eggo MC. J Cell Physiol; 2007 Sep 01; 212(3):643-54. PubMed ID: 17458906 [Abstract] [Full Text] [Related]
68. Sex steroids regulate the expression of plasminogen activator inhibitor-1 and its mRNA in fibroblasts derived from uterine endometrium. Fujimoto J, Hori M, Ichigo S, Tamaya T. Ann Clin Biochem; 1996 Nov 01; 33 ( Pt 6)():545-50. PubMed ID: 8937587 [Abstract] [Full Text] [Related]
69. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes. Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C, Ockleford CD. Placenta; 1998 Nov 01; 19(2-3):171-80. PubMed ID: 9548184 [Abstract] [Full Text] [Related]
70. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, Loskutoff DJ, Stern DM. J Clin Invest; 1998 Sep 01; 102(5):919-28. PubMed ID: 9727060 [Abstract] [Full Text] [Related]
71. Fibrinolysis: the key to new pathogenetic mechanisms. Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A. Curr Med Chem; 2008 Sep 01; 15(9):923-9. PubMed ID: 18473800 [Abstract] [Full Text] [Related]
72. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes. Heaton JH, Nebes VL, O'Dell LG, Morris SM, Gelehrter TD. Mol Endocrinol; 1989 Jan 01; 3(1):185-92. PubMed ID: 2536889 [Abstract] [Full Text] [Related]
73. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. Medcalf RL, Van den Berg E, Schleuning WD. J Cell Biol; 1988 Mar 01; 106(3):971-8. PubMed ID: 3126194 [Abstract] [Full Text] [Related]
74. Plasminogen activator levels are influenced by location and varicosity in greater saphenous vein. Shireman PK, McCarthy WJ, Pearce WH, Shively VP, Cipollone M, Kwaan HC, Yao JS. J Vasc Surg; 1996 Nov 01; 24(5):719-24. PubMed ID: 8918314 [Abstract] [Full Text] [Related]
76. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon. Niedbala MJ, Picarella MS. Blood; 1992 Feb 01; 79(3):678-87. PubMed ID: 1732009 [Abstract] [Full Text] [Related]
77. Effects of steroid hormones on fibrinolytic system in cultured human endometrial cells. Miyauchi A, Osuga Y, Taketani Y. Endocr J; 1995 Feb 01; 42(1):57-62. PubMed ID: 7599699 [Abstract] [Full Text] [Related]
78. Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells. Heaton JH, Gelehrter TD. Mol Endocrinol; 1990 Jan 01; 4(1):171-8. PubMed ID: 2157975 [Abstract] [Full Text] [Related]
79. ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA-PAI-1 and tPA-PAI-1). Grebenschikov N, Sweep F, Geurts A, Andreasen P, De Witte H, Schousboe S, Heuvel J, Benraad T. Int J Cancer; 1999 May 17; 81(4):598-606. PubMed ID: 10225451 [Abstract] [Full Text] [Related]
80. Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts. Warejcka DJ, Narayan M, Twining SS. Exp Eye Res; 2011 Nov 17; 93(5):618-27. PubMed ID: 21810423 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]